CC
GILD icon

Callan Capital’s Gilead Sciences GILD Stock Holding History

Callan Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$385K Buy
3,436
+377
+12% +$38.9K 0.03% 242
2024
Q4 		$283K Buy
3,059
+42
+1% +$3.78K 0.02% 265
2024
Q3 		$253K Sell
3,017
-2,282
-43% -$174K 0.02% 291
2024
Q2 		$364K Buy
5,299
+608
+13% +$40.6K 0.03% 206
2024
Q1 		$344K Buy
4,691
+62
+1% +$4.77K 0.03% 186
2023
Q4 		$375K Buy
+4,629
New +$360K 0.04% 151
2015
Q1 		– Sell
-2,948
Closed -$278K – 71
2014
Q4 		$278K Buy
+2,948
New +$305K 0.06% 66

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Callan Capital's GILD Position: Q1 2025 in Review

Callan Capital increased its Gilead Sciences (GILD) stake by 12% in Q1 2025, buying an estimated $38.9K and bringing the position to 3,436 shares worth $385K. The position accounts for 0.03% of the portfolio, ranked #242.

Callan Capital first reported a position in GILD in Q4 2014 and has held it in 7 quarters since. 2,016 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Callan Capital held 3,436 shares of Gilead Sciences worth $385K as of Q1 2025.
  • Callan Capital bought 377 Gilead Sciences shares in Q1 2025, an estimated $38.9K.
  • Gilead Sciences made up 0.03% of Callan Capital's portfolio in Q1 2025, its #242 holding.
  • Callan Capital first reported a position in Gilead Sciences in Q4 2014 and has held it in 7 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.